<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">06505</article-id><article-id pub-id-type="doi">10.7554/eLife.06505</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Enteric pathogens deploy cell cycle inhibiting factors to block the bactericidal activity of Perforin-2</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-27656"><name><surname>McCormack</surname><given-names>Ryan M</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-27638"><name><surname>Lyapichev</surname><given-names>Kirill</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-27639"><name><surname>Olsson</surname><given-names>Melissa L</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-24224"><name><surname>Podack</surname><given-names>Eckhard R</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" corresp="yes" id="author-23097"><name><surname>Munson</surname><given-names>George P</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology, Miller School of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country><email>gmunson@miami.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1063"><name><surname>Cossart</surname><given-names>Pascale</given-names></name><role>Reviewing editor</role><aff><institution>Institut Pasteur</institution>, <country>France</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>29</day><month>09</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e06505</elocation-id><supplementary-material><ext-link xlink:href="elife-06505-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>15</day><month>01</month><year>2015</year></date><date date-type="accepted"><day>28</day><month>09</month><year>2015</year></date></history><permissions><copyright-statement>© 2015, McCormack et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>McCormack et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Perforin-2 (MPEG1) is an effector of the innate immune system that limits the proliferation and spread of medically relevant Gram-negative, -positive, and acid fast bacteria. We show here that a cullin-RING E3 ubiquitin ligase (CRL) complex containing cullin-1 and βTrCP monoubiquitylates Perforin-2 in response to pathogen associated molecular patterns such as LPS. Ubiquitylation triggers a rapid redistribution of Perforin-2 and is essential for its bactericidal activity. Enteric pathogens such as <italic>Yersinia pseudotuberculosis</italic> and <italic>enteropathogenic Escherichia coli</italic> disarm host cells by injecting cell cycle inhibiting factors (Cifs) into mammalian cells to deamidate the ubiquitin-like protein NEDD8. Because CRL activity is dependent upon NEDD8, Cif blocks ubiquitin dependent trafficking of Perforin-2 and thus, its bactericidal activity. Collectively, these studies further underscore the biological significance of Perforin-2 and elucidate critical molecular events that culminate in Perforin-2-dependent killing of both intracellular and extracellular, cell-adherent bacteria.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd><kwd>Human</kwd><kwd>Mouse</kwd><kwd>Other</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Ryan M McCormack, may gain royalties from commercialization of USPTO patent applications PCT/US2014/059675 and PCT/US2013/032503.</p></fn><fn fn-type="conflict" id="conf3"><p>Kirill Lyapichev, may gain royalties from commercialization of USPTO patent applications PCT/US2014/059675 and PCT/US2013/032503.</p></fn><fn fn-type="conflict" id="conf4"><p>Eckhard R Podack, may gain royalties from commercialization of USPTO patent applications PCT/US2014/059675 and PCT/US2013/032503.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Research Council as stipulated by the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#13-233 and #12-257) of the University of Miami Miller School of Medicine.</p></fn></fn-group></back></article>